Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/14734462

Clin. Cancer Res. 2004 Jan 1 10 1 Pt 1 136-43

Download in:

View as

General Info

PMID
14734462